[HTML][HTML] Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT)

J Järvinen, H Pulkkinen, J Rautio, JM Timonen - Pharmaceutics, 2023 - mdpi.com
Interest in the design of boronated amino acids has emerged, partly due to the utilization of
boronophenylalanine (BPA), one of the two agents employed in clinical Boron Neutron …

4-Borono-2-18F-fluoro-l-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research

K Ishiwata - Annals of nuclear medicine, 2019 - Springer
10 B-Borono-2-18 F-fluoro-l-phenylalanine (18 F-FBPA) was developed for monitoring the
pharmacokinetics of 4-10 B-borono-l-phenylalanine (10 B-BPA) used in boron neutron …

Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism

T Nomoto, Y Inoue, Y Yao, M Suzuki, K Kanamori… - Science …, 2020 - science.org
In the current clinical boron neutron capture therapy (BNCT), p-boronophenylalanine (BPA)
has been the most powerful drug owing to its ability to accumulate selectively within cancers …

[HTML][HTML] Investigation of the impact of L-phenylalanine and L-tyrosine pre-treatment on the uptake of 4-borono-L-phenylalanine in cancerous and normal cells using an …

E Balcer, J Giebułtowicz, M Sochacka, A Ruszczyńska… - Molecules, 2023 - mdpi.com
Boron has gained significant attention in medical research due to its B-10 isotope's high
cross section for the reaction with thermal neutrons, generating ionizing particles that can …

Microdistribution and quantification of the boron neutron capture therapy drug BPA in primary cell cultures of human glioblastoma tumour by NanoSIMS

S Aldossari, G McMahon, NP Lockyer, KL Moore - Analyst, 2019 - pubs.rsc.org
The ability of secondary ion mass spectrometry (SIMS) to provide high sensitivity imaging of
elements and small-medium mass molecules in biological tissues and cells, makes it a very …

Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At] astato-α-methyl-L-phenylalanine in tumor-bearing model

Y Ohshima, H Suzuki, H Hanaoka, I Sasaki… - Nuclear Medicine and …, 2020 - Elsevier
Introduction Targeted α-radionuclide therapy has attracted attention as a promising therapy
for refractory cancers. However, the application is limited to certain types of cancer. Since L …

Influence of fluorine substituents on the properties of phenylboronic compounds

JT Gozdalik, A Adamczyk-Woźniak… - Pure and Applied …, 2018 - degruyter.com
Rapid development of research on the chemistry of boronic acids is connected with their
applications in organic synthesis, analytical chemistry, materials' chemistry, biology and …

Reliable radiosynthesis of 4-[10B]borono-2-[18F]fluoro-l-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis

K Ishiwata, R Ebinuma, C Watanabe, K Hayashi… - Annals of Nuclear …, 2018 - Springer
Objective The aim of this study was to establish a reliable and routine method for the
preparation of 4-[10 B] borono-2-[18 F] fluoro-l-phenylalanine (l-[18 F] FBPA) for boron …

[PDF][PDF] Ruszczy nska, A.; Muszy nska, M.; Bulska, E. Investigation of the Impact of L-Phenylalanine and L-Tyrosine Pre-Treatment on the Uptake of 4-Borono-L …

E Balcer, J Giebułtowicz, M Sochacka - Molecules, 2023 - ppm.wum.edu.pl
Boron has gained significant attention in medical research due to its B-10 isotope's high
cross section for the reaction with thermal neutrons, generating ionizing particles that can …

[HTML][HTML] Does Trans-Stimulation of L-Tyrosine Lead to an Increase in Boron Uptake in Head and Neck Squamous Cell Carcinoma Cells?

M Gielisch, M Moergel, B Al-Nawas, PW Kämmerer - Applied Sciences, 2021 - mdpi.com
(1) Background: For advanced head and neck squamous cell carcinoma (HNSCC), boron
neutron capture therapy (BNCT) is a potential therapeutic option, but high concentrations of …